U.S. Health Care Enforcement: Priorities and Key Regulatory Developments Webinar
Join us for our webinar with Sidley Austin to better understand the current health care enforcement landscape with the new administration.
Legal & Compliance
AdvaMed Code of Ethics 2021
Achieve the highest levels of compliance with principles on consulting arrangements, training, education and other forms of communications.
Civil Justice & Litigation Reform
AdvaMed advocates for responsible advertising for patient safety.
Value-Based Collaborations
The U.S. health care system is transitioning from a fee-for-service and fee-for-product (volume-based) model to value-based paradigm to deliver more coordinated, high-quality, affordable health care.
Exposing the Litigation Financing, Advertising and Gaming Techniques That Are Threatening American Health Care
This piece shines light on this mass tort generation machine against medical device manufacturers, explaining how it works and cautioning against the impact it is having on American healthcare.
Compliance & Ethics
To ensure collaborative relationships between medtech companies and health care professionals meet the highest ethical standards, the AdvaMed Code of Ethics provides guidance based on six cornerstone values: innovation, education,…
Physician Payments Sunshine Act
Signed into law in 2010, the Physician Payments Sunshine Act requires medical technology manufacturers operating in the U.S. to comply with specific transparency requirements. It’s important to note that the…
Legal
AdvaMed advocates on a global basis for the highest ethical standards and works to facilitate a legal environment that fosters medical technology innovation and timely patient access to safe and effective…
Global Distributor Compliance Toolkit
AdvaMed and its member companies created a comprehensive toolkit for use by all organizations in the global medical technology supply chain.
AdvaMed Applauds NJ Appellate Division for Reversing Trial Court Order Regarding FDA Evidence Admissibility
AdvaMed issued a statement regarding the decision from the New Jersey Appellate Division’s decision to remand the McGinnis case for a new trial preceded by Rule 104 hearing on the 510(k) clearance…